GOSS
NASDAQ
$0.14
Gossamer Bio Inc (GOSS)
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapies in the areas of immunology, inflammation, and oncology diseases in the United States. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $3.86 (+2634.75%)
Market Cap
$51M
Beta (5Y)
1.64
Price Chart
Valuation
Market Cap$51M
P/S0.98
P/B2.66
Profitability
Total Revenue (TTM)$56M
Gross Profit (TTM)$56M
EBITDA-$179M
Operating Margin-264.6%
EPS-$0.78
Growth & Risk
EPS 5Y CAGR-25.44%
FCF 5Y CAGR-1.61%
Beta (5Y)1.64
Sharpe Ratio-0.86